ThermoDox heat-activated liposome regulatory update

Celsion said the EMA confirmed that the company's Phase III HEAT trial is acceptable as the basis of an MAA for ThermoDox to treat hepatocellular carcinoma (HCC). The trial is evaluating progression-f...